
IPOZOAR
Zoar Limited IPO Preview: Business Combination Meets China Risk
Zoar Limited is expected to list on the NYSE on 2026-11-18, but the price range has not been disclosed. The deal is structured as a business combination rather than a standard IPO, so the key question is how investors weigh the pharma platform story against cross-border regulatory and dilution risk.
Nov 17, 20266 MIN